# Anti-Neoplastics
<!-- toc -->
# Antineoplastics Big Picture
**Goal: Stop cell growth**

**How?**
* *Block Nucleotide synthesis (Building blocks)*- **S Phase**
  * Antimetabolites: MTX, 6-MP, 5-FU
* *Block DNA replication*
  * Cross link DNA: Alkylating agents (i.e. Nitrogen mustards, nitrosoureas, Platinum agents, Busulfan)
  * Intercalates in DNA: Antibiotics
  * DNA strand break: Bleomycin, Anthracyclines
  * Block DNA unwinding: Topoisomerase inhibitors
* *Block Cellular division*- **M Phase**
  * Vinca alkaloids and Taxanes
* *Block Growth Signals*
  * Estrogen and Androgen modifiers
  * Monoclonal antibodies
  * Tyrosine Kinase inhibitors
* *Other Mechanisms*
  * L-Asparaginase and Thalidomide

**Antineoplastics Schematic**

![Antineoplastics Schematic](https://i1.wp.com/nursekey.com/wp-content/uploads/2017/05/F00045Xf45-03-9780323087896.jpg?w=960)

# Nucleotides
Nucleoside: Base + Sugar

Nucleotide: Base + Sugar + Phosphate

Drugs that block Base synthesis- All work during Synthesis (S) Phase
* Block Purines (Adenine, Guanine)
  * 6-Mercaptopurine, 6-Thioguanine
  * Mycophenolate, Ribavirin
* Block Pyrimidines (Cytosine, Uracil, Thymine)
  * Leflunomide
  * Methotrexate
  * 5-Fluorouracil, Cytarabine
  * Hydroxyurea

# Purine Analogues (TODO)
## 6-Mercaptopurine (6-MP)
## Mycophenolate
## Ribavirin

# Folic Acid Antagonists
## Methotrexate (MTX)

*MOA:* Inhibit **Dihydrofolate reductase** inhibiting Tetrahydrofolate
synthesis thus inhibiting thymidine synthesis

*Use:*
* Neoplastic use: Leukemias, lymphomas
* Non-Neoplastic: RA, Psoriasis, Ectopic pregnancy, Inflammatory Bowel Disease

*SE:*
* ***Myelosuppression (WBC, RBC, Platelet)***
* Oral ulcers
* ***Pulmonary Fibrosis***
* Hepatotoxicity

## Leucovorin (Folinic Acid)

*MOA:* Form of tetrahydrofolate bypasses dihydrofolate reductase

*Use:* Reverse myelosuppression caused by MTX

# Pyrimidine Analogues
## 5-Flurouracil (5-FU)

*MOA:* Pyrimidine analogue which complexes with and **inhibits
Thymidylate Synthase** inhibiting Thymidine Synthesis

*Use:*
* Solid growing tumors: Colon cancer, pancreatic cancer
* **Effects enhanced by addition of leucovorin**
  * Leucovorin stabilizes 5-FU binding to Thymidylate synthase

*SE:* Myelosuppression

## Cytarabine
*MOA:* Pyrimidine analogue incorporates into DNA and inhibits DNA polymerase

*Use:* Acute Myelogenous Leukemia

*SE:* Myelosuppression

# Nitrogen Mustards
## Cyclophosphamide / lfosfamide
*MOA:* Cross link DNA inhibiting DNA replications

*Use:*
* Solid tumors
* Non-Hodgkin's Lymphoma
* Autoimmune disease: SLE, RA

*SE:*
* Myelosuppression
* **Hemorrhagic cystitis caused by acrolein in the preparation***
  * Prevented by hydration and MESNA- thiol group in MESNA

## Melphalan
* Used for Multiple Myeloma


# Nitrosoureas
## Carmustine / Lomustine
*MOA:* Cross link DNA and **Cross the blood brain barrier**

*Use:* Brain tumors

*SE:*
* CNS toxicity (Seizure)
* Myelosuppression

# Platinum Agents
## Cisplatin / Carboplatin / Oxaliplatin
*MOA:* Cross link DNA
*Use:*
* Testicular and Ovarian Cancer
*SE:* All related to free radicals
* **Nephrotoxicity**, Hypomagnesemia and hypokalemia
  * Prevent with amifostine (free radical scavenger) and hydration
* Peripheral neuropathy
* Ototoxicity

Carboplatin is least toxic

# Other Alkylating Agents
## Busulfan
*MOA:* Cross links DNA

*Use:* CML

*SE:*
* ***Severe Myelosuppression***
  * Sometimes used to ablate patient bone marrow before bone marrow transplant
* **Pulmonary Fibrosis**

## Procarbazine/Dacarbazine
*MOA:* Not fully understood- Possibly break DNA strands

*Use:* Lymphomas, others

*SE:*
* **Inhibits Alcohol formaldehyde causing Disulfiram reaction**
  * Avoid ETOH Use
* **Inhibits Monoamine Oxidase enzyme (MAO) causing Hypertensive Crisis with
foods containing Tyramine (Aged cheese and wine)**
  * Tyramine displaces NE from synaptic cleft- NE is normally broken down by MAO
  * Extra unbroken NE causes HTN

# Natural Antibiotics
## Actinomycin D
*MOA:* Intercalates in DNA

*Use:* **Childhood tumors- Mostly primitive tumors**
* Wilms Tumor (Nephroblastoma- Tumor of the adrenal medulla)
* Ewing Sarcoma (Primitive tumor of the bone)
* Rhabomyosarcoma

*SE:* Myelosuppression

## Bleomycin
*MOA:* Induces free radical formation causing DNA breaks- **Inhibits DNA Ligase during G2 Phase**

*Use:* Testicular cancer

*SE:* Pulmonary Fibrosis

*What Other Antineoplastic causes Pulmonary Fibrosis?*
* Bleomycin, MTX, Busulfan

# Anthracyclines
## Doxorubicin/Daunorubicin/Epirubicin

**Suffix- Bicin**

*MOA:* Generates free radicals causing DNA breaks using free iron

*Use:* Breast cancer, lymphomas, leukemias

*SE:*
* **Dilated Cardiomyopathy related to iron deposits in the heart from the drug**
  * Need MUGA scan to evaluate heart function before starting
  * **Dexrazoxane** is an iron chelating agent used to prevent cardiotoxicity
  * **Epirubicin is least cardiotoxic**
* Severe alopecia

# Topoisomerase Inhibitors

## Etoposide (TOPO II)

*MOA:* Inhibits *Topoisomerase II* inhibiting DNA unwinding and replication

*Use:* Solid tumors (Testicular tumors and lung)

*SE:* Myelosuppression, Alopecia

## Irinotecan, Topotecan (TOPO 1)
*MOA:* Inhibits *Topoisomerase I*

*Use:* Colon, Ovarian and lung

*SE:*
* Severe myelosuppression
* **Severe Diarrhea** (Due to suppression of Gl cells which have high turnover rates)

# How do Cells Divide/Move?
* Cells use microtubules which are composed of helix of polymerized heterodimers (Alpha and Beta tubulin)
* Microtubules are incorporated into flagella, cilia mitotic spindles X
* Involved in
  * Mitosis (Anticancer: Vinca and Taxanes)
  * White blood cell extravasation (Anti Gout - Colchicine)
  * Sperm/Cilia movement
  * Axoplasmic transport
  * Fungus and worms moving *(Antifungal: Griseofulvin and Anthelmintic: Mebendazole)*

# Vinca Alkaloids & Taxanes
## Vinblastine/Vincristine
*MOA:* Bind B-Tubulin and **inhibits its polymerization into microtubules**
preventing mitotic spindle formation- cell can't divide
* Works specifically in M-Phase

*Use:*
Vincristine: Hodgkin's Lymphoma
Vinblastine: Metastatic testicular tumors

*SE:*
* VinBlastine: **Bone marrow suppression**
* Vincristine: **Peripheral neuropathy (Areflexia, peripheral neuritis, constipation)**


## Paclitaxel/Docetaxel
*MOA:* **Hyper Stabilize** polymerized microtubules in M Phase
-> mitotic spindles can’t break down
-> cell can't divide

*Use:* Ovarian and breast

*SE
* Hypersensitivity
* Myelosuppression, neuropathy

# Chemo Regimens Examples

* **Wilms Tumor**: Actinomycin D, Vincristine, Cyclophosphamide
* **Colon Cancer**: 5-FU, Adriamycin (Doxorubicin), Mitomycin
* **Cervical Carcinoma**: Vincristine
* **Pancreatic Cancer**: Gemcitabine

# Hormonal Big Picture
## **Estrogen** dependent tissue
* **Breast** (Breast Cancer)
  * Breast cancer status
    * Estrogen(ER) +ve/-ve, Progesterone (PR) +ve/-ve, Her2/Neu +ve/-ve
    * ER +ve breast CA treatment
      * Block Estrogen- Tamoxifen
      * Block Androgen conversion to Estrogen- Aromatase Inhibitors
* **Endometrium** (Endometrial Cancer)
* **Bone** (Deficiency leads to osteoporosis)
## **Androgen** dependent tissue
* **Prostate** (Benign Prostatic Hyperplasia, Prostate Cancer)
* Prostate CA Treatment
  * Block Gonadotropin/Androgen axis- Leuprolide/Goserelin
  * Block Testosterone conversion to DHT- Flutamide

## Estrogen Modifiers/Inhibitors
### Tamoxifen

*MOA:* Selective estrogen receptor modulator(SERM)
* **Antagonist in breast**
* **Agonist in Bone & Endometrium**

*Use:* ER +ve breast cancer

*SE:*
* **Endometrial carcinoma (Agonist in Endometrium)**
* **Thromboembolic events** (i.e. DVT/PE) because Estrogen increases clotting factors synthesis by liver
* Hot flashes

### Aromatase Inhibitors
**Anastrozole/Letrozole/Exemestane**
*MOA:* Inhibit Aromatase enzyme responsible for peripheral conversion of androgens to estrogen

*Use:* ER+ve breast cancer in postmenopausal women

**Source of estrogen**
  * Pre-menopausal: Ovaries
  * Postmenopausal: Peripheral conversion

## Androgen Inhibitors
### GnRH Analogues: Leuprolide/Goserelin
*MOA:* GnRH analogues
* When used in **pulsatile** fashion: **Agonists**
* When used **continuously: Antagonists** because it downregulates GnRH receptors in pituitary leading to decreased FSH/LH)

*Use:*
* Prostate Adenocarcinoma (Decrease LH— Decrease Androgens)
* Other indications

*SE:*
* Transient disease flare in initial treatment because of agonist property- treated with flutamide

### Flutamide
*MOA:* Nonsteroidal competitive inhibitor at the Dihydrotestosterone (DHT) receptor

*Use:* Prostate Adenocarcinoma

# Monoclonal Antibodies
## Trastuzumab
*MOA:* Blocks **Her2/Neu Tyrosine Kinase Receptor**

*Use:* Her2/Neu +ve Breast Cancer

*SE:* Cardiotoxicity
## Rituximab
*MOA:* Blocks **CD20** found on most B-Cell neoplasm

*Use:* Non-Hodgkin's Lymphoma, Chronic Myeloid Leukemia

*SE:* Infusion related reactions
## Cetuximab
*MOA:* Blocks **EGFR**

*Use:* Stage IV Colon Cancer
## Bevacizumab
*MOA:* Blocks **VEGF** Inhibiting angiogenesis

*Use:* Solid tumors, proliferative diabetic retinopathy, macular degeneration

*SE:* Impaired wound healing
## Bortezomib
**Proteasome Inhibitor inducing apoptosis at G2-M Phase**
(Proteasomes degrade damaged ubiquitin tagged proteins)

Use: **Multiple Myeloma**


# Tyrosine Kinase Inhibitors
## Imatinib
*MOA:* Tyrosine kinase inhibitor

*Use:*
* Specific for BCR-ABL tyrosine kinase (Philadelphia chromosome) in Chronic Myeloid Leukemia
* C-Kit tyrosine kinase in Gl stromal tumors (mesenchymal origin)

*SE:* Fluid Retention

## Erlotinib/Gefitinb
*MOA:* Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor

*Use:* **Non-Small Cell lung cancer**

# Gene Therapy
## CART-T therapy
**CTLO19 (Tisagenlecleucel)**

*MOA:* T cells isolated from patients, genetically altered to recognize the B-cell marker CD19.

*Use:* ALL and B-cell lymphomas

*SE:* Cytokine release syndrome (flu-like symptoms to life threatening respiratory distress)

# Miscellaneous
## L-Asparaginase
*MOA:*
* Enzyme produced by Escherichia coli
* I-Asparagine is a nonessential amino acid
  * Most cells can synthesize except certain **lymphoid malignancies**
* **L-asparaginase depletes I-Asparagine** in Tumor cells w/ low or no levels asparagine synthetase

*Use:* ALL

*SE:* Hypersensitivity and resistance

## Hydroxyurea

*MOA:* Inhibits ribonucleotide reductase

*Uses:*
* Historically - CML
* Currently - **Sickle cell anemia**
  * **Increase Fetal Hbg**

*SE:* Myelosuppression

## Thalidomide & Lenalidomide
*MOA:*
* **Unknown**
* Stimulates T and natural killer cells, inhibits
angiogenesis and modulates hematopoietic stem cell differentiation

*Use:*
* **Multiple myeloma**
* Lenalidomide - myelodysplastic syndrome

*SE:*
* Thalidomide: **sedation & peripheral neuropathy**
* Lenalidomide (Less toxicity) **leukopenia**, hepatotoxicity and renal dysfunction.

## Vorinostat

*MOA:*
* Histone deacetylase inhibitor
* Acetylated histones relax chromatin structure which allows more **transcription -> cell cycle arrest**

*Uses:* Cutaneous T cell lymphomas

*SE:* DVT/PE, thrombocytopenia, and anemia.
